EPSTI1
EPSTI1 (epithelial stromal interaction 1) is a human protein implicated in M1 macrophage polarisation and in NF-κB activation. It is also known as BRESI1 and MGC29634, and was previously named epithelial stromal interaction 1 (breast). Browse Assay Genie's current range of EPSTI1 research reagents below, or read on for the biology behind the target.
EPSTI1 plays a role in M1 macrophage polarisation and is required for the proper regulation of gene expression during M1 versus M2 macrophage differentiation. It may also contribute to the phosphorylation and nuclear localisation of RELA/p65 and STAT1 when macrophages are activated, placing it close to the inflammatory signalling that defines the M1 state.
The EPSTI1 protein interacts with the amino-terminal region of the valosin-containing protein gene product. This interaction results in nuclear translocation of the nuclear factor kappa B subunit 1 gene product and activation of NF-κB target genes. Expression of the EPSTI1 gene is upregulated by direct binding of Kruppel-like factor 8 to promoter sequences. The mouse and rat orthologues are both named Epsti1.
The name derives from the original description of the gene in an epithelial-stromal interaction context in breast tissue, reflected in the earlier symbol BRESI1. EPSTI1 has been shown to promote tumour invasion and metastasis in some invasive cancer cells when overexpressed. Overexpression has also been observed in some breast cancers and in some individuals with systemic lupus erythematosus (SLE), making it a point of interest in both oncology and autoimmune research.
EPSTI1 is required for proper gene expression regulation during M1 versus M2 macrophage differentiation, making it relevant to studies of macrophage activation states.
EPSTI1 may influence RELA/p65 and STAT1 phosphorylation and nuclear localisation, and promotes NF-κB subunit translocation through its interaction with valosin-containing protein.
Overexpression of EPSTI1 promotes invasion and metastasis in some invasive cancer cells and has been observed in some breast cancers.
Overexpression of EPSTI1 has been observed in some individuals with systemic lupus erythematosus, linking the gene to immune dysregulation.
EPSTI1 plays a role in M1 macrophage polarisation and in regulating gene expression during M1 versus M2 differentiation. It interacts with valosin-containing protein, which leads to nuclear translocation of the NF-κB subunit and activation of target genes. It may also affect RELA/p65 and STAT1 phosphorylation.
The HGNC name is epithelial stromal interaction 1, and UniProt lists the protein as epithelial-stromal interaction protein 1. Aliases and previous symbols are BRESI1 and MGC29634. An earlier name was epithelial stromal interaction 1 (breast), reflecting the original breast context.
Overexpression of EPSTI1 promotes tumour invasion and metastasis in some invasive cancer cells and has been seen in some breast cancers and some individuals with SLE. Orthologues exist in mouse and rat, both called Epsti1; check the datasheet of any product for its validated reactivity.
Macrophage polarisation regulators, NF-κB and STAT1 pathway components and EPSTI1 binding or regulatory partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96J88; product specifications from Assay Genie datasheets.